N,N-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 97%, 5g

N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 95%, 1g

2,8-Diazaspiro[4.5]decan-1-one hydrochloride, 95.0%, 250mg

Ethyl 2,4-dibromobutanoate, 95.0%, 1g

1-(METHOXYMETHYL)-2,6-DIMETHYLCYCLOHEXANOL, 95.0%, 250mg

Éther diéthylique, min 99,5 %, Ph.Eur., stab., 2,5 l, emballage en verre

{[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}amine hydrochloride hydrate, 95.0%, 1g

4-Bromophenol, 95%, 100g

5-Bromoquinoline-8-carboxylic acid, 95.0%, 25g

2,2,2-Trifluoro-1-(2-methoxyphenyl)ethylamine, 95.0%, 1g

L-N-[4'-Boc-Piperidino]proline, 98.0%, 1g

2,5-Dibromotoluene, 98.0%, 100g

tert-butyl 3-(benzylamino)-2-methylpropanoate, 95.0%, 2g